Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer. - Wikidata - awgldk - TriplyDB

Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer.

Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer.

http://www.wikidata.org/entity/Q34462255

about

Inhibition of cathepsin B activity attenuates extracellular matrix degradation and inflammatory breast cancer invasion Stromal cell expression of caveolin-1 predicts outcome in breast cancer Caveolin-1, a stress-related oncotarget, in drug resistance Inflammatory breast cancer: New factors contribute to disease etiology: A review Signal transducer and activator of transcription 5A/B in prostate and breast cancers Rac1 and Cdc42 are regulators of HRasV12-transformation and angiogenic factors in human fibroblasts.Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer.Association of caveolin-1 and -2 genetic variants and post-treatment serum caveolin-1 with prostate cancer risk and outcomes.Caveolin-1: a tumor-promoting role in human cancer.Alternate estrogen receptors promote invasion of inflammatory breast cancer cells via non-genomic signaling Cathepsin B: a potential prognostic marker for inflammatory breast cancer Epigenetic modifications of caveolae associated proteins in health and disease.Human monocytes augment invasiveness and proteolytic activity of inflammatory breast cancer.Caveolin-1 expression in benign and malignant lesions of the breast.Phenotypic and Molecular Characterization of MCF10DCIS and SUM Breast Cancer Cell Lines.Is caveolin-1 a viable therapeutic target to reduce cancer metastasis?Foetal haemoglobin-blood cells (F-cells) as a feature of embryonic tumours (blastomas).Caveolin-1 Modulates Docetaxel-Induced Cell Death in Breast Cancer Cell Subtypes through Different Mechanisms Overexpression of caveolin-1 is sufficient to phenocopy the behavior of a disease-associated mutant Expression of ALDH1 in breast invasive ductal carcinoma: an independent predictor of early tumor relapse.SWOG S0800 (NCI CDR0000636131): addition of bevacizumab to neoadjuvant nab-paclitaxel with dose-dense doxorubicin and cyclophosphamide improves pathologic complete response (pCR) rates in inflammatory or locally advanced breast cancer.CpG island shore methylation regulates caveolin-1 expression in breast cancer Caveolae mediate growth factor-induced disassembly of adherens junctions to support tumor cell dissociation The estrogen receptor α is the key regulator of the bifunctional role of FoxO3a transcription factor in breast cancer motility and invasiveness.The role of caveolin-1 in prostate cancer: clinical implications.The different functions and clinical significances of caveolin-1 in human adenocarcinoma and squamous cell carcinoma.The role of caveolin-1 in human breast cancer.Caveola-forming proteins caveolin-1 and PTRF in prostate cancer.Overexpression of caveolin-1 in inflammatory breast cancer cells enables IBC-specific gene delivery and prodrug conversion using histone-targeted polyplexes.Caveolin-1 mediates inflammatory breast cancer cell invasion via the Akt1 pathway and RhoC GTPase.1,25 Dihydroxyvitamin D3 uptake is localized at caveolae and requires caveolar function.Differential effects of vitamin D treatment on inflammatory and non-inflammatory breast cancer cell lines.Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype.Caveolin-1 P132L mutation in human cancers: 1 CAVeat to be voiced.Bidirectional alteration of Cav-1 expression is associated with mitogenic conversion of its function in gastric tumor progression.Caveolin-1 and -2 regulate cell motility in castration-resistant prostate cancer

P2860

Q22000757-8ACB538F-4C3F-48D2-A704-889F8409399D Q24658345-38EF0656-0601-482C-AABE-5BD2FE53B001 Q26782615-DD55B0D8-3B4D-41E0-AE52-A5715DC2F4D8 Q27027856-4535EEAD-0DDD-46CC-977B-ABC98B4FF820 Q28281791-2447AFE3-E4FC-43E1-B31D-42137929D582 Q33523409-A89F1AD8-556C-4193-AA72-6D91DB7A8E29 Q33870504-D1A24D27-ACAC-4F76-94B5-D86A762B7BB1 Q33872530-EA99F8BE-2519-4A49-9C3E-55746AC14390 Q34010128-24E6B0CE-E6DE-4B6E-AEB2-6AE856C5FD68 Q34147662-B19F0226-753A-4928-8129-B6CD901E5D5B Q34499322-257FA19F-2B68-49A8-B368-3B68304E9432 Q35674847-8E65A591-9C49-4C59-98ED-02382736D504 Q36109380-90B67535-5EE2-4E21-81D5-6DD0D6BC7F87 Q36152220-5FCB7E55-92AE-4D91-AAE5-2C373F3B02CB Q36582681-62C0D700-6B18-4329-985C-394604221BCC Q36596684-5067866E-2C78-4861-8B60-13802897C6FB Q36610921-F4EEC11D-3EB6-4879-A490-7909743A0789 Q36832200-7A56BC6C-E3B4-4941-8495-E62140A2872D Q36907381-46BA3F1F-E00B-47B7-965B-9229BA63BFAE Q36958447-2B3D18A3-1EDF-4144-B9F8-EC3B3764F36B Q37131869-831F56D0-29A3-471B-BF20-EA75D6AC7EF4 Q37209244-36286C06-0D02-487C-9353-BF27D4DF9C79 Q37369865-4217C77B-71FD-48E6-ADB5-16C3DE6C88A4 Q37492303-50BCAD08-9830-4B19-9D52-7E2CD1AE8735 Q37542947-3025DB54-3D72-4A43-B2A3-A242946A93BD Q37652986-256643AD-25E5-4508-9F6D-F1229CBAF36A Q37928979-C68AB621-FB53-4522-A9C6-38D7DACD250B Q38128481-EECBDCFA-FAD4-477C-B438-9CB33B353333 Q38736601-AB540FEA-56C6-471B-96F1-82F67D71287D Q38923177-7BACB919-9A3E-4D6B-BC93-72BDAAC08C22 Q39098423-C1C04E9B-9AE6-43D3-BA88-538B136BDFC0 Q39345445-D595492A-C83F-4BBA-9845-0515A08AFA3B Q40809878-64AFCF07-51B9-4C0E-A35B-81C5E25E8F4E Q42054988-F4A5A411-4FD1-4794-8964-D155CE67514A Q49583955-3EBE10EE-3277-48C2-964D-863B22C20107 Q57484740-B16A1A5B-AAF8-4D3E-A8E6-C9115AFF7CE1

P2860

Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer.

http://www.wikidata.org/entity/Q34462255

description

2005 nî lūn-bûn

@nan

2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Overexpression of caveolin-1 a ...... of inflammatory breast cancer.

@ast

Overexpression of caveolin-1 a ...... of inflammatory breast cancer.

@en

Overexpression of caveolin-1 a ...... of inflammatory breast cancer.

@nl

type

label

Overexpression of caveolin-1 a ...... of inflammatory breast cancer.

@ast

Overexpression of caveolin-1 a ...... of inflammatory breast cancer.

@en

Overexpression of caveolin-1 a ...... of inflammatory breast cancer.

@nl

prefLabel

Overexpression of caveolin-1 a ...... of inflammatory breast cancer.

@ast

Overexpression of caveolin-1 a ...... of inflammatory breast cancer.

@en

Overexpression of caveolin-1 a ...... of inflammatory breast cancer.

@nl

P1433

Q34462255-F1F4EAA5-F366-4C37-8DF7-28A3BD04A91E

P1476

Q34462255-239632CB-69DC-4717-B152-4B216A85FDAC

P2093

Q34462255-2341814B-6A0B-4478-82C4-13517CF8EE55

Q34462255-31F50910-45AB-4971-9CE6-999E84FE168D

Q34462255-3DDEC5AC-3C84-4735-AB4A-52CC9D798F3B

Q34462255-44559EE2-3C70-4072-B677-5FE1F7668BD0

Q34462255-87F7B6E6-C825-4E7A-AD9C-354272998327

Q34462255-8E4E14D7-CCBC-4595-8A85-AC040E239892

Q34462255-A047753A-6EC8-4E96-99F3-9F96741BB577

Q34462255-B0AF7C31-2F4D-4A14-A950-B4EF6495EBEB

Q34462255-D9E5B9D9-D932-4438-80FA-8AD059189F1B

P2860

Q34462255-0A70E11F-DD27-4B12-AB44-9405A914E3FF

Q34462255-820D53D2-2158-442F-BB17-42C83038EF1C

Q34462255-D8FADB6B-4F8E-40AC-AC52-260FDED37FA8

P2888

Q34462255-915BF4DC-C472-4DF4-AAFD-E295B6266CC5

P304

Q34462255-A765D7AE-BAD5-45B3-B001-99E543975826

P31

Q34462255-7D58D7C2-55F6-4E6D-BB6F-37C4ED3D6095

P356

Q34462255-81A39589-7930-45CD-B557-D0F1C9ABEC07

P407

Q34462255-4CE60CB5-F165-4F66-A759-F2CD7CE9D165

P433

Q34462255-5BA211F7-72FD-4EDC-9EF4-CA14D509B798

P478

Q34462255-6B194CE9-C550-49D4-B7B5-C5FF2CF3D84D

P577

Q34462255-1270F9A5-769D-432E-8979-3D3057C610E1

P5875

Q34462255-B2AC164A-D87D-48A4-AD1A-2B27F9D5CE14

P6179

Q34462255-2408804A-655D-4E4B-8DBC-35D426409DFC

P698

Q34462255-5EEB2215-AC23-4BD2-8D15-99244C8A1E60

P921

Q34462255-55761CAB-F90F-46D2-B552-478BAC5BBCAB

P356

S10549-005-9002-1

P1433

Breast Cancer Research and Treatment

P1476

Overexpression of caveolin-1 a ...... of inflammatory breast cancer.

@en

P2093

Eric A Van Marck

http://www.w3.org/2001/XMLSchema#string

Gert G Van den Eynden

http://www.w3.org/2001/XMLSchema#string

Ilse Van der Auwera

http://www.w3.org/2001/XMLSchema#string

Kenneth L van Golen

http://www.w3.org/2001/XMLSchema#string

Luc Y Dirix

http://www.w3.org/2001/XMLSchema#string

Peter B Vermeulen

http://www.w3.org/2001/XMLSchema#string

Peter van Dam

http://www.w3.org/2001/XMLSchema#string

Sofia D Merajver

http://www.w3.org/2001/XMLSchema#string

Steven J Van Laere

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability

Expression and significance of RhoC gene in hepatocellular carcinoma.

NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression.

P2888

s10549-005-9002-1

P304

219-228

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10549-005-9002-1

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P577

2005-10-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7521438

http://www.w3.org/2001/XMLSchema#string

P6179

1049329503

http://www.w3.org/2001/XMLSchema#string

P698

16244790

http://www.w3.org/2001/XMLSchema#string

P921